CareCycle Targets Medicare Shopping Friction With Free Voice AI Plan Comparator
CareCycle has introduced a free tool for Medicare beneficiaries designed to make open enrollment feel less like a sales funnel and more like a structured benefits review. The product, called Match Your Medicare, is available without an account, does not take payments from payers, and does not collect commissions. It also does not sell or share personal information, a feature that lands squarely in the middle of one of the most sensitive points in coverage selection: trust.
The tool asks users for a ZIP code, date of birth and gender, then builds plan comparisons from those inputs. Beneficiaries can also optionally enter doctors, prescriptions and health conditions, which allows the system to surface yearly cost estimates tied to premiums, copays and drug coverage. Users can compare up to three plans side by side, a structure that mirrors the practical decision-making many older adults face when trying to match coverage to real-world utilization rather than marketing language.
A Medicare shopper who learns too late that a prescription is excluded has already lost the most important negotiation window.
Why Network Fit and Drug Coverage Drive the Medicare Decision
The timing of the launch matters because Medicare’s Open Enrollment period is the one interval when beneficiaries can still make meaningful changes before coverage choices harden into another year of copays, prior authorizations and pharmacy surprises. CareCycle’s pitch is straightforward: many enrollment failures happen because patients focus on extras such as OTC cards, Part B givebacks or grocery allowances while skipping the harder questions about physician networks and formularies. In practice, that means a plan can look generous on the surface and still fail at the bedside if a patient’s cardiologist, oncologist, inhaler or anticoagulant falls outside the network or drug list.
The company says it most often hears from people after enrollment when a medication is not covered or unexpected costs appear. Alex Doonanco, co-founder and CEO, framed those failures as questions that can be answered before a person signs, and the product is built around that premise. The logic is clinical as much as administrative. When a beneficiary loses access to a familiar physician or a stable drug regimen, the downstream burden can include disrupted chronic disease control, delayed refills and more time spent navigating exceptions instead of receiving care.
The tool also includes a video guide that walks users through each step and can help fill in forms by voice as users speak. That matters in a population where manual navigation, digital literacy and hearing or vision barriers can all interfere with plan comparison. Voice interaction can reduce friction for people who struggle with dense web forms, and in that sense the product is less about novelty than about lowering the activation energy required to complete a health insurance task that is often unnecessarily complex.
Voice AI Moves Further Into Enrollment Support Workflows
CareCycle is not positioning itself as only a consumer-facing comparison engine. The Y Combinator-backed company also sells tools for human customer service teams and uses AI voice agents for post-enrollment outreach, including welcome calls, 90-day check-ins and reminders about expiring benefits. The company says its agents have logged more than 30,000 hours of calls and helped agencies support more than 1 million people after enrollment.
Those numbers suggest the company has focused on the administrative follow-through that usually gets less attention than the enrollment moment itself. In Medicare, the first choice is rarely the last one. A beneficiary who signs up can still run into network changes, benefit expirations, utilization management or a prescription mismatch months later, and a well-timed outreach call can surface those problems before they become grievances or care gaps. Voice AI is useful here because many of these interactions are repetitive, highly scripted and time-sensitive, yet still require a conversational format that text messaging does not always provide.
CareCycle’s current product reflects a broader shift in payer-adjacent technology: automation is moving upstream into selection and downstream into retention. The company’s plan comparison tool sits at the front end of that workflow, where the consequences of a bad fit are expensive but still avoidable. If the system can reliably surface a doctor mismatch or drug exclusion before enrollment, it could reduce the volume of the very calls the company later has to handle after coverage begins.
Forced Disenrollment Adds Urgency to Plan Selection
The launch also lands against a more volatile Medicare Advantage backdrop. One analysis found that forced disenrollment averaged 1% among Medicare Advantage enrollees annually from 2018 through 2024, then rose to 7% in 2025 and 10% in 2026. The same analysis estimated that nearly 3 million Medicare Advantage beneficiaries will have to find new plans or switch to traditional Medicare this year.
Those figures explain why a comparison tool that checks physician networks and drug coverage has more than consumer convenience value. When people are pushed to change plans, they are forced into a compressed decision process, often while trying to preserve continuity with specialists, pharmacies and chronic medications. In that setting, a tool that can estimate annual costs and check network participation may help beneficiaries avoid a choice made under pressure and based on the wrong signal.
The broader market problem is plain: plan design, sales incentives and beneficiary priorities do not always point in the same direction. Marketing often emphasizes perks that are easy to advertise and hard to evaluate, while the clinically relevant questions are slower and less visible. Does the plan cover the prescriptions the patient already takes? Are the physicians already involved in care still in network? What will the year actually cost once copays and drugs are counted? CareCycle’s tool is built to answer those questions directly.
In a market where beneficiaries may be forced to move between plans with little warning, the core issue is not whether the software is clever. It is whether it can reduce the number of patients who discover, after enrollment, that the plan they chose cannot support the care they already need.